Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.44 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.44 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 9/20 | 0.43 |
| ▸ | PDE4A | P27815 | 8/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 8/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 8/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.43 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1866522 | 0.78 | PDE4A (0.49) | ALDH1A1ADORA2BADORA2APDE4APDE4B | |
| SCHEMBL18560720 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ATAD2ADORA2BADORA2APDE4A | |
| SCHEMBL16513159 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ATAD2ADORA2BADORA2APDE4A | |
| SCHEMBL29950717 | 0.77 | PIK3CG (0.53) | ALDH1A1PIK3CGPIK3C3KDM4ENPC1 | |
| SCHEMBL2117284 | 0.77 | CYP2C19 (0.48) | ALDH1A1PIK3CGPIK3C3KDM4ENPC1 | |
| SCHEMBL8354950 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ATAD2ADORA2BADORA2APDE4A | |
| SCHEMBL94914 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ATAD2ADORA2BADORA2APDE4A | |
| SCHEMBL612165 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ATAD2ADORA2BADORA2APDE4A | |
| SCHEMBL7684288 | 0.75 | ALDH1A1 (0.50) | ALDH1A1KDM4ENPC1ADORA2BADORA2A | |
| SCHEMBL7990063 | 0.73 | ALDH1A1 (0.47) | ALDH1A1PIK3CGPIK3C3KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595486-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-04-07 | — | — | US | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-12584136-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2026-03-24 | — | — | US | claimed |
| US-12559515-B2 | Cap compounds and RNAS comprising the same | HELIX NANOTECHNOLOGIES INC (US) | 2026-02-24 | — | — | US | claimed |
| US-12359205-B2 | Aptamers for personal health care applications | THE PROCTER & GAMBLE COMPANY (US) | 2025-07-15 | — | — | US | claimed |
| US-20250206770-A1 | CAP COMPOUNDS AND RNAS COMPRISING THE SAME | HELIX NANOTECHNOLOGIES INC | 2025-06-26 | — | — | US | claimed |
| WO-2025137486-A1 | CAP COMPOUNDS AND RNAS COMPRISING THE SAME | HELIX NANOTECHNOLOGIES INC (US) | 2025-06-26 | — | — | WO | claimed |
| EP-3664776-B1 | APTAMERS FOR CONSUMER PRODUCT COMPOSITIONS | PROCTER & GAMBLE (US) | 2025-05-14 | — | — | EP | claimed |
| EP-4448767-A1 | APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS | The Procter & Gamble Company (US) | 2024-10-23 | — | — | EP | claimed |
| EP-4448768-A1 | APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS | The Procter & Gamble Company (US) | 2024-10-23 | — | — | EP | claimed |
| EP-3665282-A1 | APTAMERS FOR ORAL CARE APPLICATIONS | THE PROCTER & GAMBLE COMPANY (US) | 2020-06-17 | — | — | EP | claimed |
| US-10676748-B2 | Aptamers for consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2020-06-09 | — | — | US | claimed |
| WO-2019032795-A1 | APTAMERS FOR ORAL CARE APPLICATIONS | THE PROCTER & GAMBLE COMPANY (US) | 2019-02-14 | — | — | WO | claimed |
| US-20190048348-A1 | Aptamers For Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2019-02-14 | — | — | US | claimed |
| WO-2019032811-A1 | APTAMERS FOR CONSUMER PRODUCT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2019-02-14 | — | — | WO | claimed |
| US-20190048349-A1 | APTAMERS FOR ORAL CARE APPLICATIONS | NEOVENTURES BIOTECHNOLOGY INC. (CA) | 2019-02-14 | — | — | US | claimed |
| EP-3401683-A1 | DIAGNOSING METABOLIC DISEASE BY THE USE OF A BIOMARKER | Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) | 2018-11-14 | — | — | EP | claimed |
| CN-105548407-B | The detection method of modified nucleoside in urine | 杭州汉库医学检验所有限公司 | 2017-07-14 | — | — | CN | claimed |
| CN-105548407-A | Detecting method for modified nucleoside in urine | HANGZHOU HEALTH-BANK MEDICAL LABORATORY CO LTD | 2016-05-04 | — | — | CN | claimed |
| WO-2016043661-A1 | MODIFIED PEPTIDE NUCLEIC ACIDS AND THEIR USE | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-03-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584136-B2 | Aptamers for personal health care applications | HAVCR2, LDLR, ICAM1 | ALDH1A1 2579/4885PIK3CG 4538/4885PIK3C3 4512/4885 |
| US-20250206770-A1 | CAP COMPOUNDS AND RNAS COMPRISING THE SAME | RNGTT, RNMT, NSUN2 | ALDH1A1 1939/4885PIK3CG 2400/4885PIK3C3 2399/4885 |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | GLS, AADAT, FGF23 | ALDH1A1 822/4885PIK3CG 2060/4885PIK3C3 3998/4885 |
| US-12595486-B2 | Aptamers for personal health care applications | HAVCR2, EPCAM, ICAM1 | ALDH1A1 1974/4885PIK3CG 4595/4885PIK3C3 4549/4885 |
| US-12559515-B2 | Cap compounds and RNAS comprising the same | RNMT, RNGTT, NSUN2 | ALDH1A1 2010/4885PIK3CG 2275/4885PIK3C3 2110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.